<DOC>
	<DOCNO>NCT00044148</DOCNO>
	<brief_summary>The purpose study determine 1 ) Whether Ly333531 reduce urinary albumin/creatinine excretion patient Type II diabetes persistent albuminuria 2 ) Whether LY333531 reduce urinary TGF-B , 3 ) safety LY333531 side effect may associate .</brief_summary>
	<brief_title>The Effect LY333531 Protein Urine Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Ruboxistaurin</mesh_term>
	<criteria>Type 2 diabetes mellitus Greater equal 30 year age Albumin Creatinine ratio ( great 200 mg/g less 2000 mg/g ) 4 ) Without language barrier . Serum Creatinine great 2.0 mg/dl male great 1.7 mg/dl female B/P great 150 systolic great 90 diastolic Hemoglobin Alc great 11 % Liver Function Tests 2 time upper limit normal Poor medical psychiatric risk .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Persistent Albuminuria</keyword>
</DOC>